Underpriced stock with substantial value Acb still has been the underdog waiting to unlock shareholder value. Compared with its peers this co is only at a fraction of other industry names.
the reverse split didn't do any good to the co though in the hindsight apart from ensuring the nyse compliance.
would love to see this co soar after positive next quarters and a clear cut US legalization strategy.
my conservative short term price target is $50
timeline is safe banking act/ US legalization/decriminalization, needless to add positive EBITDA is expected in the next quarters as per the CEO's nov update on extension